Evidence map›Paper›PMID 19651855›Full record

ArticleInfection and immunity2009

Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN.

Nicole N Driessen, Roy Ummels, Janneke J Maaskant, Sudagar S Gurcha, Gurdyal S Besra, Gary D Ainge, David S Larsen, Gavin F Painter, Christina M J E Vandenbroucke-Grauls, Jeroen Geurtsen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Generation of Liposomes to Study the Effect ofInternational journal of molecular sciences · 2021
    Article
  13. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Murine SIGNR1 (CD209b) Contributes to the Clearance of UropathogenicFrontiers in cellular and infection microbiology · 2019
    Article
  18. Underestimated Manipulative Roles ofFrontiers in immunology · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Nicole N DriessenDepartment of Medical Microbiology and Infection Control, Medical Faculty, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
Roy Ummels
Janneke J Maaskant
Sudagar S Gurcha
Gurdyal S Besra
Gary D Ainge
David S Larsen
Gavin F Painter
Christina M J E Vandenbroucke-Grauls
Jeroen Geurtsen
Ben J Appelmelk
Amsterdam UMC Location VUmc · NLUniversity of Birmingham · GBUniversity of Otago · NZ

Funding

TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTINGN01AI075320 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · 1997 to 2004
$980k
NIAID NIH HHS N01 AI-75320
6 · The paper itself

Abstract

The C-type lectin dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) is the major receptor on DCs for mycobacteria of the Mycobacterium tuberculosis complex. Recently, we have shown that although the mannose caps of the mycobacterial surface glycolipid lipoarabinomannan (ManLAM) are essential for the binding to DC-SIGN, genetic removal of these caps did not diminish the interaction of whole mycobacteria with DC-SIGN and DCs. Here we investigated the role of the structurally related glycolipids phosphatidylinositol mannosides (PIMs) as possible ligands for DC-SIGN. In a binding assay with both synthetic and natural PIMs, DC-SIGN exhibited a high affinity for hexamannosylated PIM(6), which contains terminal alpha(1-->2)-linked mannosyl residues identical to the mannose cap on ManLAM, but not for di- and tetramannosylated PIM(2) and PIM(4), respectively. To determine the role of PIM(6) in the binding of whole mycobacteria to DC-SIGN, a mutant strain of M. bovis bacillus Calmette-Guérin deficient in the production of PIM(6) (Delta pimE) was created, as well as a double knockout deficient in the production of both PIM(6) and the mannose caps on LAM (Delta pimE Delta capA). Compared to the wild-type strain, both mutant strains bound similarly well to DC-SIGN and DCs. Furthermore, the wild-type and mutant strains induced comparable levels of interleukin-10 and interleukin-12p40 when used to stimulate DCs. Hence, we conclude that, like ManLAM, PIM(6) represents a bona fide DC-SIGN ligand but that other, as-yet-unknown, ligands dominate in the interaction between mycobacteria and DCs.

Indexed as

Bacterial AdhesionCell Adhesion MoleculesCells, CulturedDC-Specific ICAM-3 Grabbing NonintegrinDendritic CellsGene DeletionHumansInterleukin-10Interleukin-12 Subunit p40Lectins, C-TypeMycobacterium bovisMycobacterium tuberculosisPhosphatidylinositolsProtein BindingReceptors, Cell SurfaceCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinInterleukin-10Interleukin-12 Subunit p40Lectins, C-Typephosphatidylinositol mannosidePhosphatidylinositolsReceptors, Cell Surface

Identifiers

PMID19651855
PMCPMC2747922
OpenAlexW2165828990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.